Alnylam Pharmaceuticals (ALNY) Tax Rate (2009 - 2026)
Alnylam Pharmaceuticals (ALNY) reported Tax Rate of 7.07% for Q1 2026, up 67780.0% on a YoY basis from N/an in Q1 2025, and up 124.11% quarter-over-quarter from 29.31% in Q4 2025.
Alnylam Pharmaceuticals (ALNY) Tax Rate (2009 - 2026) Analysis & Trends
Alnylam Pharmaceuticals has reported Tax Rate for 12 years, with the latest figure at 7.07% in Q1 2026.
- For the quarter ending Q1 2026, Tax Rate rose 67780.0% year-over-year to 7.07%; the trailing twelve-month figure through Mar 2026 stood at 1.66% (down 2544.0% YoY), and the FY2025 full-year result was 2.91%, down 2338.0% from the prior year.
- Tax Rate for Q1 2026 stood at 7.07%, up from 29.31% in the prior quarter.
- The five-year high for Tax Rate was 56.81% in Q4 2024, with the low at 670.73% in Q1 2025.
- Historically, Tax Rate has averaged 46.29% across 5 years, with a median of 0.99% in 2022.
- Annual changes were most pronounced in 2025 — Tax Rate tumbled 66704 bps — and 2026, when it surged 67780 bps.
- Alnylam Pharmaceuticals' Tax Rate stood at 0.23% in 2022, then surged by 42 bps to 0.13% in 2023, then soared by 42846 bps to 56.81% in 2024, then tumbled by 152 bps to 29.31% in 2025, then jumped by 124 bps to 7.07% in 2026.
- The last three Tax Rate figures came in at 7.07% (Q1 2026), 29.31% (Q4 2025), and 4.32% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -57.14 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -6.79 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 5.61 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 17.68 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Alnylam Pharmaceuticals | 37.04 Bn | 34.03 Bn | 959.66 Mn | 7.07 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.07% |
| Mar 31, 2026 | 7.07% |
| Dec 31, 2025 | -29.31% |
| Dec 31, 2025 | -29.31% |
| Sep 30, 2025 | -4.32% |
| Sep 30, 2025 | -4.32% |
| Jun 30, 2025 | -87.45% |
| Jun 30, 2025 | -87.45% |
| Mar 31, 2025 | -670.73% |
| Mar 31, 2025 | -670.73% |
| Dec 31, 2024 | 56.81% |
| Dec 31, 2024 | 56.81% |
| Sep 30, 2024 | -2.68% |
| Sep 30, 2024 | -2.68% |
| Jun 30, 2024 | -51.24% |
| Jun 30, 2024 | -51.24% |
| Mar 31, 2024 | -3.69% |
| Mar 31, 2024 | -3.69% |
| Dec 31, 2023 | -0.13% |
| Dec 31, 2023 | -0.13% |